MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0025287
Redicare Pharma Private Limited
Redicare Pharma Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.43 Cr
▲ 22% YoY
Net profit · FY 2025
₹6.34 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹13.75 Lakh
EBITDA margin 4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹27.69 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Redicare Pharma Private Limited
Data last updated:
Redicare Pharma Private Limited is a private limited company based in Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 22 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2011PTC225352. Its GSTIN is 09AAGCR0849D2ZD (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Adesh Srivastava and Sushil Srivastav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 1170 Metro Vihar Phase – II Holambi Kalan, Delhi, India – 110082.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.43 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6.34 Lakh (net margin 1.9%) and EBITDA of ₹13.75 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹27.69 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Redicare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0025287). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2011PTC225352
Registration Number 225352
Incorporation Date 22 September 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0025287
Recognitions & Rankings of Redicare Pharma
Contact details
Redicare Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 1170 Metro Vihar Phase – II Holambi Kalan, Delhi, India – 110082
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Redicare Pharma Private Limited, buy the company report.
Comprehensive company report
Redicare Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Redicare Pharma is hospital and medical care. In detail, this covers counselling, welfare, referral activities without accommodation for elderly and disabled.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q5 | Counselling, welfare, referral activities without accommodation for elderly and disabled |
To see the full business activity and turnover split of Redicare Pharma Private Limited, buy the company report.
Financials of Redicare Pharma Private Limited
FY 2025 filings availableRedicare Pharma Private Limited reported revenue of ₹3.43 Cr (up 22% YoY) for FY 2025.
Revenue · FY 2025
₹3.43 Cr ▲ 22%
Net profit · FY 2025
₹6.34 Lakh margin 1.9%
EBITDA · FY 2025
₹13.75 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 27%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 14%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 22% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Redicare Pharma Private Limited, buy the company report.
Board of directors of Redicare Pharma Private Limited
Redicare Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adesh Srivastava | Director | 22 Sep 2011 | 15 Years 1 Months | Current |
| Sushil Srivastav | Director | 22 Sep 2011 | 15 Years 1 Months | Current |
| Ravi Kant Srivastava | Director | 22 Sep 2011 | 15 Years 1 Months | Current |
Peer comparison
Redicare Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (counselling, welfare, referral activities without accommodation for elderly and disabled), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| In-Sync Centre for Child Development and Autism Therapy Private Limited | ₹4.07 Cr (FY 2025) | 106.0% | Hyderabad, Telangana, India | |||
| Shreeraksha Labs Private Limited | ₹4.05 Cr (FY 2025) | 26.0% | Bangalore, Karnataka, India | |||
| Indicure Health Tours Private Limited TFR. From Maharashtra to Delhi | ₹3.81 Cr (FY 2025) | 106.0% | New Delhi, Delhi, India | |||
| Lets Habilitate Clinic (OPC) Private Limited | ₹3.79 Cr (FY 2025) | 35.0% | Mansoorabad, Telangana, India | |||
| Psoriatreat Psoriasis Research and Homeopathic Clinics Private Limited | ₹3.57 Cr (FY 2024) | -4.0% | Pune, Maharashtra, India | |||
| Redicare Pharma Private Limitedthis company | ₹3.43 Cr (FY 2025) | ₹6.34 Lakh | 1.9% | 22.0% | Delhi, India | |
| Mental Health and Research Private Limited | ₹3.41 Cr (FY 2024) | 39.0% | Indore, Madhya Pradesh, India | |||
| Pragyan Childdevelopmentcentre Private Limited | ₹3.38 Cr (FY 2025) | 189.0% | Bangalore, Karnataka, India | |||
| Ohxto Healthcare Private Limited | ₹3.14 Cr (FY 2024) | 25.0% | Thane, Maharashtra, India | |||
| PFC Club (India) Private Limited | ₹3.02 Cr (FY 2024) | 69.0% | Pune, Maharashtra, India | |||
| Dr.S.K.Jains Burlington Clinic Private Limited | ₹2.98 Cr (FY 2024) | -5.0% | Delhi, India |
To see the full peer comparison of Redicare Pharma Private Limited, buy the company report.
Auditor
Redicare Pharma Private Limited is audited by R. CHAUDHARY & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. CHAUDHARY & CO. | FY 2017 | 020138C |
Shareholding
The shareholding of Redicare Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Redicare Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹27.69 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2025 | 101187113 | Hdfc Bank Limited | ₹9.03 Lakh | Open | |
| 25 Jun 2021 | 100472806 | Hdfc Bank Limited | ₹7.47 Lakh | Open | |
| 29 Oct 2020 | 100411310 | Hdfc Bank Limited | ₹11.2 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Redicare Pharma Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| District court, Varanasi, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Disposed |
To see the full case history of Redicare Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Redicare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Redicare Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCR0849D2ZD | Uttar Pradesh | Active | 22 Jul 2017 |
To see the full GST registrations and return filing status of Redicare Pharma Private Limited, buy the company report.
Recent activity
Redicare Pharma Private Limited has 3 board changes on record since 2011: 3 appointments. The latest: Adesh Srivastava was appointed as Director on 22 Sep 2011.
AGM
Redicare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.03 Lakh with Charge ID 101187113 was registered on 29 Sep 2025.
Filing
Redicare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.47 Lakh with Charge ID 100472806 was registered on 25 Jun 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.20 Lakh with Charge ID 100411310 was registered on 29 Oct 2020.
Appointed
Adesh Srivastava was appointed as Director.
Appointed
Ravi Kant Srivastava was appointed as Director.
Appointed
Sushil Srivastav was appointed as Director.
Incorporation
22 Sep 2011
Redicare Pharma Private Limited was registered on 22 Sep 2011 with Roc Delhi Ii & aged 15 years 1 month as per MCA records.
Frequently asked questions
Redicare Pharma is an active private limited company based in Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 22 September 2011 (15+ years old) and is registered under CIN U51909DL2011PTC225352.
Redicare Pharma has 3 current directors:
- Adesh Srivastava - Director
- Sushil Srivastav - Director
- Ravi Kant Srivastava - Director
The latest financial statements of Redicare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Redicare Pharma is 09AAGCR0849D2ZD, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Redicare Pharma is U51909DL2011PTC225352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redicare Pharma has 3 court cases on record: 3 filed against it. 2 are pending.
Redicare Pharma was incorporated on 22 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Redicare Pharma by revenue are In-Sync Centre for Child Development and Autism Therapy Private Limited, Shreeraksha Labs Private Limited, Indicure Health Tours Private Limited TFR. From Maharashtra to Delhi, Lets Habilitate Clinic (OPC) Private Limited, Psoriatreat Psoriasis Research and Homeopathic Clinics Private Limited and 5 more, all in the same principal business activity (counselling, welfare, referral activities without accommodation for elderly and disabled).
Adesh Srivastava was appointed as Director on 22 Sep 2011. Ravi Kant Srivastava was appointed as Director on 22 Sep 2011. Sushil Srivastav was appointed as Director on 22 Sep 2011.
Yes, Redicare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0025287).
The registered office of Redicare Pharma is at B – 1170 Metro Vihar Phase – II Holambi Kalan, Delhi, India – 110082.